MiNK Therapeutics Inc. (INKT)
NASDAQ: INKTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 8, 1:09 PM ET
INKT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $56.29M
- EPS (TTM)
- -$2.39
- Dividend yield
- None
- 52-week range
- 8.48 – 16.93
- Day range
- 10.96 – 11.56
- Volume / Avg
- 8.53K / 14.20K
- Beta
- —
- Shares outstanding
- 5.10M
52-week range
INKT stock today
MiNK Therapeutics (INKT) is trading at $11.03 on Oct 8, down 3.42% (-$0.39), versus the S&P 500's 0.65% decline. At this level, INKT sits in the middle of its 52-week range of $8.48 to $16.93: 34.8% below the high, set on Mar 10, 2026 and 30.1% above the low. INKT is up 2.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 23.4%.
MiNK Therapeutics has posted a net loss over the last twelve months (EPS of -$2.39), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About MiNK Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- New York, NY
- IPO year
- 2021
MiNK Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KLRSKalaris Therapeutics Inc. | 2.49 | -2.73% | $59.27M | vs INKT |
| ELOXEloxx Pharmaceuticals Inc. | 14.91 | +0.20% | $60.18M | vs INKT |
| LONALeonaBio Inc. | 5.77 | -1.11% | $54.32M | vs INKT |
| EXOZeXoZymes Inc. | 5.60 | +0.99% | $52.06M | vs INKT |
| CRBUCaribou Biosciences Inc. | 0.4825 | -21.80% | $51.73M | vs INKT |
| INMBINmune Bio Inc. | 1.85 | -0.54% | $51.34M | vs INKT |
| BKHABlack Hawk Acquisition Corporation Class A | 12.35 | -5.00% | $51.30M | vs INKT |
| CSBRChampions Oncology Inc. | 4.90 | +0.31% | $68.13M | vs INKT |
Indexes, lists and sector
MiNK Therapeutics stock FAQ
What is MiNK Therapeutics's stock price today?
INKT last traded at $11.03 as of Oct 8, 1:09 PM EDT, down 3.42% on the day. Prices are delayed at least 15 minutes.
Does MiNK Therapeutics pay a dividend?
No. MiNK Therapeutics does not currently pay a regular cash dividend.
Has INKT ever split its stock?
Yes. The most recent INKT stock split was a 1-for-10 split on Jan 28, 2025.
What is the INKT 52-week high?
The 52-week high for INKT is $16.93 and the 52-week low is $8.48. The stock is currently 34.8% below its high.